BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, March 18, 2024
See today's BioWorld
Home
» Public Biotech Funding Nearly Doubles in H1 2011 vs. H1 2010
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Public Biotech Funding Nearly Doubles in H1 2011 vs. H1 2010
July 11, 2011
By
Trista Morrison
No Comments
Biotech companies raised a total of $13.3 billion in the first half of 2011, up a whopping 64 percent over the $8.1 billion raised in the first half of 2010, according to data from BioWorld Insight and BioWorld Snapshots.
BioWorld